Current position:Home >Product >
L-Leucine,N2-(2-naphthalenylcarbonyl)-D-lysyl-L-asparaginyl-L-glutaminyl-L-tryptophyl-L-alanyl-L-valyl-D-alanyl-L-histidyl-,cyclic (9®1)-peptide (9CI)
L-Leucine,N2-(2-naphthalenylcarbonyl)-D-lysyl-L-asparaginyl-L-glutaminyl-L-tryptophyl-L-alanyl-L-valyl-D-alanyl-L-histidyl-,cyclic (9®1)-peptide (9CI)(168434-09-1)
- Name: L-Leucine,N2-(2-naphthalenylcarbonyl)-D-lysyl-L-asparaginyl-L-glutaminyl-L-tryptophyl-L-alanyl-L-valyl-D-alanyl-L-histidyl-,cyclic (9®1)-peptide (9CI)
- Synonyms:PTC808
- Molecular Formula:C60H79 N15 O12
- Molecular Weight:
- CAS Registry Number:168434-09-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 13360-45-7/CHLORBROMURON
- 6379-69-7/trichothecin
- 68937-95-1/Imidazolium compounds, 2-(C15 and C17-unsatd. alkyl)-1-(2-(C16 and C18-unsatd. amido)ethyl)-1-ethyl-4,5-dihydro, Et sulfates
- 65188-64-9/Ethyl acrylate, acrylonitrile, itaconic acid, N-methylolacrylamide,acrylic acid polymer
- 68783-28-8/Castor oil, polymer with azelaic acid, glycerol and phthalic anhydride
- 75348-52-6/3,5,6-trichloro-1-methylpyridin-2(1H)-one
- 5334-53-2/4-methoxy-1-methyl-1H-pyrazolo[3,4-d]pyrimidine
- 339164-14-6/Benzenesulfonic acid, 4-hydroxy-, reaction products with formaldehyde, 2-((4-hydroxyphenyl)sulfonyl)phenol and 4,4-sulfonylbis(phenol), sodium salts
- 274-80-6/1,7,8-triazabicyclo[4.3.0]nona-2,4,6,8-tetraene
- 405238-92-8/4-amino-5-fluoro-1-[(2S,5S)-3-fluoro-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2(1H)-one
- 67815-86-5/1,6-Hexanediol, polymer with 1,3-diisocyanatomethylbenzene and 2-ethyl- 2-(hydroxymethyl)-1,3-propanediol Toluene diisocyanate, trimethylolpropane, 1,6-hexanediol polymer
- 64687-01-0/3-ethyl-6-phenyl-2-thioxo-2,3-dihydro[1,3]thiazolo[4,5-d]pyrimidin-7(6H)-one
- 73972-92-6/4-(4-butoxybenzyl)-2-[2-(diethylamino)ethyl]phthalazin-1(2H)-one hydrochloride
- 35541-77-6/cyclohexane-1,4-diyldimethanediyl dimethanesulfonate
- 25763-09-1/L-Phenylalaninamide,L-isoleucyl-L-seryl-L-a-aspartyl-L-arginyl-L-a-aspartyl-O-sulfo-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-a-aspartyl-
- 951-77-9/2'-Deoxycytidine monohydrate
- 7319-55-3/trimethyl-[2-[[2-octadecanoyloxy-3-[(Z)-octadec-9-enoyl]oxy-propoxy]-o xido-phosphoryl]oxyethyl]azanium
- 30531-86-3/Colfenamate
- 168434-09-1/L-Leucine,N2-(2-naphthalenylcarbonyl)-D-lysyl-L-asparaginyl-L-glutaminyl-L-tryptophyl-L-alanyl-L-valyl-D-alanyl-L-histidyl-,cyclic (9®1)-peptide (9CI)
- 7666-04-8/2-(Methylthio)imidazole
- 7575-18-0/N-(4-acetamido-2,5-diaziridin-1-yl-3,6-dioxo-1-cyclohexa-1,4-dienyl)acetamide
- 103651-09-8/N-(3-hydroxyhexadecanoyl)-alpha-glutamyl-N-[3-(3-amino-3-oxopropyl)-23-(2-carboxyethyl)-6-(4-hydroxybenzyl)-20-(1-hydroxyethyl)-26-methyl-9-(1-methylpropyl)-1,4,7,10,18,21,24,27-octaoxo-1,2,3,4,5,6,7,8,9,10,16,17,18,19,20,21,22,23,24,25,26,27,29,30,31,31a
- 66357-59-3/Ranitidine Hydrochloride
- 152986-49-7/Spiro[22,26-methano-20H,24H-furo[2,3-h][1,5]dioxacyclohexacosin-24,2'-[2H]pyran]-20-one,13-[[5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]oxy]-2,3,3',3a,4',5',6,6',7,8,9,10,11,12,13,14,15,16,17,22,23,26,27,27a-tetracosahydro-11,12,14,16,27a-pentahydroxy-6'-(2-hydroxybutyl)-2,2,11,15,17,28-hexamethyl-(9CI)
- 202527-41-1/Olean-12-ene-23,28-dioic acid,3-(â-D-glucopyranosyloxy)-2,27- dihydroxy-,28-[O-6-O-acetyl-â-Dglucopyranosyl-( 1f3)-O-[O-â-D-galactopyranosyl-( 1f4)-O-â-D-xylopyranosyl- (1f4)-6-deoxy-R-L-mannopyranosyl-(1f2)]- 6-deoxy-4-O-[(2Z)-3-(3,4-dimethoxyphenyl)- 1-oxo-2-propenyl]-â-D-galactopyranosyl] ester,(2â,3â,4R)-
- 2219-30-9/D(-)PENICILLAMINE HYDROCHLORIDE
- 74137-77-2/10-(4-methylpiperazin-1-yl)-7-(methylsulfanyl)-4H-thieno[3,4-b][1,5]benzodiazepine
- 85877-87-8/methyl 4-[(4-{[2-methyl-1-(oxoacetyl)hydrazinyl]sulfonyl}phenyl)amino]-4-oxobutanoate
- 64050-88-0/3-(carbamoyloxy)-N,N,N-trimethylpropan-1-aminium iodide
- 1340-02-9/Methyl purple